Selective Molecular Alterations in the Autophagy Pathway in Patients with Lewy Body Disease and in Models of α-Synucleinopathy
Open Access
- 19 February 2010
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 5 (2), e9313
- https://doi.org/10.1371/journal.pone.0009313
Abstract
Lewy body disease is a heterogeneous group of neurodegenerative disorders characterized by α-synuclein accumulation that includes dementia with Lewy bodies (DLB) and Parkinson's Disease (PD). Recent evidence suggests that impairment of lysosomal pathways (i.e. autophagy) involved in α-synuclein clearance might play an important role. For this reason, we sought to examine the expression levels of members of the autophagy pathway in brains of patients with DLB and Alzheimer's Disease (AD) and in α-synuclein transgenic mice. By immunoblot analysis, compared to controls and AD, in DLB cases levels of mTor were elevated and Atg7 were reduced. Levels of other components of the autophagy pathway such as Atg5, Atg10, Atg12 and Beclin-1 were not different in DLB compared to controls. In DLB brains, mTor was more abundant in neurons displaying α-synuclein accumulation. These neurons also showed abnormal expression of lysosomal markers such as LC3, and ultrastructural analysis revealed the presence of abundant and abnormal autophagosomes. Similar alterations were observed in the brains of α-synuclein transgenic mice. Intra-cerebral infusion of rapamycin, an inhibitor of mTor, or injection of a lentiviral vector expressing Atg7 resulted in reduced accumulation of α-synuclein in transgenic mice and amelioration of associated neurodegenerative alterations. This study supports the notion that defects in the autophagy pathway and more specifically in mTor and Atg7 are associated with neurodegeneration in DLB cases and α-synuclein transgenic models and supports the possibility that modulators of the autophagy pathway might have potential therapeutic effects.Keywords
This publication has 89 references indexed in Scilit:
- Rapamycin activation of 4E-BP prevents parkinsonian dopaminergic neuron lossNature Neuroscience, 2009
- Role of Synucleins in Alzheimer’s DiseaseNeurotoxicity Research, 2009
- Nutrient-dependent regulation of autophagy through the target of rapamycin pathwayBiochemical Society Transactions, 2009
- Cathepsin D Is the Main Lysosomal Enzyme Involved in the Degradation of α-Synuclein and Generation of Its Carboxy-Terminally Truncated SpeciesBiochemistry, 2008
- Organization of the Pre-autophagosomal Structure Responsible for Autophagosome FormationMolecular Biology of the Cell, 2008
- Dopamine-modified α-synuclein blocks chaperone-mediated autophagyJCI Insight, 2008
- Autophagic Stress in Neuronal Injury and DiseaseJournal of Neuropathology and Experimental Neurology, 2006
- Loss of autophagy in the central nervous system causes neurodegeneration in miceNature, 2006
- Eating Oneself and Uninvited GuestsCell, 2005
- Neuropathological stageing of Alzheimer-related changesActa Neuropathologica, 1991